Some of the most intensively studied phytocannabinoids are CBD (Cannabidiol) and CBG (Cannabigerol). Interestingly, both compounds interact with different receptors within our endocannabinoid system in a complementary manner.
This means that CBD acts at cannabinoid receptor type 1 and 2 (CB1/2), while CBG acts mostly on cannabinoid receptor type 2 (CB2).
The recent surge in public awareness about CBD brought even more attention to all the other cannabinoids especially CBG. This is not surprising given that CBG benefits also increase significantly when combined with, for example, CBD or THC.
There is still much research to be done on this subject but so we know that both compounds act differently. CBG has a greater affinity to CB2 receptors whereas CBD exerts its effects more readily through CB1 receptors.
The human body produces some cannabinoids on its own, e.g., endocannabinoids. Our bodies can synthesize only small amounts of these cannabinoids, however, and cannot always meet our increased needs with the natural production alone. This is where phytocannabinoids come into play. They not only boost the effects of endocannabinoids but also interact with other non-cannabinoid receptors within the brain and immune system.
This article summarizes what is already known about CBD vs CBG … Read More